Corient Capital Partners’s VeriSign VRSN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
$1.16M Buy
6,929
+118
+2% +$21.8K 0.09% 194
2022
Q2
$1.14M Buy
6,811
+2,488
+58% +$456K 0.09% 199
2022
Q1
$962K Buy
4,323
+1,069
+33% +$233K 0.06% 256
2021
Q4
$826K Buy
3,254
+556
+21% +$129K 0.05% 267
2021
Q3
$553K Buy
2,698
+737
+38% +$161K 0.04% 336
2021
Q2
$447K Buy
1,961
+662
+51% +$144K 0.03% 384
2021
Q1
$258K Sell
1,299
-779
-37% -$153K 0.02% 494
2020
Q4
$450K Sell
2,078
-158
-7% -$32.3K 0.05% 294
2020
Q3
$458K Sell
2,236
-125
-5% -$25.8K 0.05% 269
2020
Q2
$488K Buy
2,361
+265
+13% +$55K 0.06% 252
2020
Q1
$377K Buy
2,096
+527
+34% +$104K 0.06% 263
2019
Q4
$302K Buy
1,569
+38
+2% +$7.14K 0.04% 355
2019
Q3
$289K Buy
1,531
+43
+3% +$8.84K 0.04% 347
2019
Q2
$311K Sell
1,488
-146
-9% -$28.7K 0.05% 299
2019
Q1
$297K Buy
+1,634
New +$280K 0.05% 282

Other funds holding VRSN

Corient Capital Partners's VRSN Position: Q3 2022 in Review

Corient Capital Partners increased its VeriSign (VRSN) stake by 1.7% in Q3 2022, buying an estimated $21.8K and bringing the position to 6,929 shares worth $1.16M. The position accounts for 0.09% of the portfolio, ranked #194.

Corient Capital Partners first reported a position in VRSN in Q1 2019 and has held it in 15 quarters since. 566 funds tracked by Wall St. Rank hold VRSN as of Q3 2022.

  • Corient Capital Partners held 6,929 shares of VeriSign worth $1.16M as of Q3 2022.
  • Corient Capital Partners bought 118 VeriSign shares in Q3 2022, an estimated $21.8K.
  • VeriSign made up 0.09% of Corient Capital Partners's portfolio in Q3 2022, its #194 holding.
  • Corient Capital Partners first reported a position in VeriSign in Q1 2019 and has held it in 15 quarters since.
  • 566 funds tracked by Wall St. Rank held VeriSign as of Q3 2022.

Based on Corient Capital Partners's 13F filing for Q3 2022, filed 14 Nov 2022.